{"id":6705,"date":"2024-11-04T17:33:18","date_gmt":"2024-11-04T17:33:18","guid":{"rendered":"https:\/\/idealmedical.co.za\/wp\/?post_type=product&p=6705"},"modified":"2024-11-04T17:35:49","modified_gmt":"2024-11-04T17:35:49","slug":"ck-nac-sl-clinical-chemistry-reagent-elitech","status":"publish","type":"product","link":"https:\/\/idealmedical.co.za\/wp\/product\/ck-nac-sl-clinical-chemistry-reagent-elitech\/","title":{"rendered":"CK NAC SL Clinical Chemistry Reagent, Elitech"},"content":{"rendered":"
INTENDED USE<\/strong> CLINICAL SIGNIFICANCE<\/strong> LIMITATION OF USE<\/strong> COMPOSITION<\/strong> Reagent 2 : R2 MATERIALS REQUIRED BUT NOT PROVIDED<\/strong> INTENDED USE ELITech Clinical Systems CK NAC SL is an in vitro diagnostic reagent intended for the quantitative determination of creatine kinase (CK) in human serum and plasma samples on analyzers or semi-automatic analyzers. This in vitro diagnostic device is for professional use only. CLINICAL SIGNIFICANCE Creatine kinase (CK) exists in 3 cytoplasmic forms: CK-MM […]<\/p>\n","protected":false},"featured_media":6562,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[130],"product_tag":[],"class_list":{"0":"post-6705","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-elitech-clinical-chemistry","8":"first","9":"onbackorder","10":"shipping-taxable","11":"purchasable","12":"product-type-variable"},"yoast_head":"\n
\nELITech Clinical Systems CK NAC SL is an in vitro diagnostic reagent intended for the quantitative determination of creatine kinase (CK) in human serum and plasma samples on analyzers or semi-automatic analyzers.
\nThis in vitro diagnostic device is for professional use only.<\/p>\n
\nCreatine kinase (CK) exists in 3 cytoplasmic forms:
\nCK-MM (dominant isoenzyme in striated and cardiac muscles), CK MB (mostly in cardiac muscle), and CKBB (only isoenzyme in brain).
\nEnzymatic activity of total creatine kinase is increased during muscle damage such as Duchenne dystrophy,
\nrhabdomyolysis, inflammatory diseases, myocardia infarction and trauma.
\nCertain antipsychotic drugs (olanzapine and quetiapine), and in some cases hypothyroidism, also trigger
\nelevated total CK activity.
\nDetermination of total CK is used to help diagnose and to follow-up conditions associated with muscle
\ndamage.<\/p>\n
\nThe quantitative assay of creatine kinase (CK) alone cannot be used to diagnose a disease or a specific
\npathology.
\nThe results must be interpreted in conjunction with other diagnostic test results, clinical findings and the
\npatient\u2019s medical history<\/p>\n
\nReagent 1 : R1
\nImidazole buffer, pH 6.1 (20 \u00b0C)
\nD-Glucose 25 mmol\/L
\nNADP 2.5 mmol\/L
\nHexokinase \u2265 6 800 U\/L
\nSodium azide < 0.1 % (w\/w)<\/p>\n
\nImidazole buffer, pH 8.9 (20 \u00b0C)
\nCreatine phosphate 250 mmol\/L
\nADP 15.2 mmol\/L
\nG-6-PDH \u2265 8 800 U\/L
\nSodium azide < 0.1 % (w\/w)
\nAlso contains magnesium salts, N-acetyl cysteine,E DTA, diadenosine pentaphosphate and AMP for optimal performance.<\/p>\n
\n– CALI-0550 ELICAL 2
\n– CONT-0060 ELITROL I
\n– CONT-0160 ELITROL II
\n– Normal saline solution (NaCl 9 g\/L).
\n– Analyzers or semi-automatic analyzers.
\n– General Laboratory equipment (e.g. pipette).
\n– Do not use materials that are not required as indicated above<\/p>\n","protected":false},"excerpt":{"rendered":"